MELOXICAM TABLETS 1
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc. a contract valued at $5.18 under solicitation SPE2DP26F8317, with an award date of July 27, 2026. This award is a delivery order under the parent contract SPE2DX25D9900 and pertains to the procurement of Meloxicam Tablets 1, identified by NSN 6505017349294 and PR 7017646888. The contract is classified as a federal award issued by the Department of Defense through its Defense Logistics Agency, with no specified set-aside or NAICS code. Performance location and point of contact details are not provided, and the full record can be accessed via the DIBBS portal. The very low monetary value suggests this is likely a minor or placeholder order, possibly for testing, trial quantities, or administrative purposes within a larger procurement framework.
General Info
Agency
Contract Value
$5.18NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
